AFFIMED GMBH has a total of 97 patent applications. It increased the IP activity by 750.0%. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are GORMAN SCOTT DAVID, ELSTAR THERAPEUTICS INC and NANJING LEADS BIOLABS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 15 | |
#2 | Australia | 10 | |
#3 | United States | 10 | |
#4 | Canada | 9 | |
#5 | WIPO (World Intellectual Property Organization) | 9 | |
#6 | Brazil | 8 | |
#7 | China | 8 | |
#8 | Republic of Korea | 5 | |
#9 | Singapore | 5 | |
#10 | Israel | 3 | |
#11 | Mexico | 3 | |
#12 | Hong Kong | 2 | |
#13 | Hungary | 2 | |
#14 | Serbia | 2 | |
#15 | South Africa | 2 | |
#16 | Chile | 1 | |
#17 | Colombia | 1 | |
#18 | Peru | 1 | |
#19 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Preservation of human bodies | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Reusch Uwe | 75 |
#2 | Treder Martin | 56 |
#3 | Ellwanger Kristina | 52 |
#4 | Fucek Ivica | 46 |
#5 | Rajkovic Erich | 43 |
#6 | Ross Thorsten | 31 |
#7 | Weichel Michael | 30 |
#8 | Knackmuss Stefan | 27 |
#9 | Little Melvyn | 24 |
#10 | Koch Joachim | 22 |
Publication | Filing date | Title |
---|---|---|
WO2020043670A1 | Cryopreserved nk cells preloaded with an antibody construct | |
AU2019252970A1 | NK cell engaging antibody fusion constructs | |
CA3090464A1 | Bispecific egfr/cd16 antigen-binding protein | |
EP3589316A1 | Combination of an anti-cd16a antibody with a cytokine | |
CA3051062A1 | Tandem diabody for cd16a-directed nk-cell engagement | |
EP3366704A1 | Antibodies specific for mmp1/hla-a2 complex | |
CA2983706A1 | Combination of a cd30xcd16 antibody with a pd-1 antagonist for therapy | |
EP3156417A1 | Multivalent fv antibodies | |
EP3091031A1 | Combination of a bispecific antibody with an immune modulating molecule for the treatment of a tumor | |
US2015225484A1 | Antigen-binding molecule and uses thereof | |
EP3030581A1 | Antibody binding sites specific for egfrviii | |
EP2361936A1 | Antigen-binding molecule and uses thereof | |
EP1400534A1 | Human CD3-specific antibody with immunosuppressive properties |